UiPath’s (NYSE:PATH) Q2 CY2026 Sales Top Estimates

UiPath (NYSE: PATH) reported Q2 CY2026 revenue of $410.3M, up 13.4% YoY, beating estimates. Guidance for next quarter is $442.5M. Non-GAAP EPS was $0.15, in line with expectations. 5-year revenue growth is 18.5% annualized, but 2-year growth slowed to 11.6%. ARR is $1.94B, with 11.7% YoY growth. CAC payback period was negative.

Original reporting
Published Sep 3, 2026, 9:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 3, 2026, 9:29 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
UiPath’s (NYSE:PATH) Q2 CY2026 Sales Top Estimates — source image
Decision brief

The 30-second read

$PATHNeutralHigh
01

Why it matters

Earnings beat provides short-term support but slower growth metrics may temper enthusiasm.

02

Market read

First report of Q2 results for a mid‑cap automation firm; material for traders.

03

What to watch

ARR growth lagging behind total revenue and negative CAC payback indicate margin pressure.

Relevance 8/10Novelty 8/10Timing: after-hours release

Background

UiPath is a leading RPA provider transitioning to broader automation solutions.

Company-level read

Ticker impact

$PATHNeutralHigh confidence
Context

UiPath reported Q2 CY2026 revenue of $410.3M, beating estimates by 3.1% and provided guidance for the next quarter.

Expected impact

Potential modest upside if investors focus on beat; downside risk if growth slowdown concerns dominate.

Evidence & confidence

The beat is material, but guidance is in line with estimates, limiting upside.

Market effects

RPA and automation software sector may see renewed investor interest after beat.

US tech equities could see slight lift in automation subsector.

Limited; impact confined to automation software niche.

Counterpoint

Growth slowdown and negative CAC payback suggest a potential pullback despite the beat.

Key entities

  • UiPath

    Automation software provider (NYSE:PATH).

Related articles

$LULUHighAI 8/10

Stocks making the biggest moves after hours: Lululemon, Zscaler, Guidewire Software & more

Lululemon (LULU) fell 18% after weak Q3 guidance. Docusign (DOCU) rose 4% on earnings beat. Zscaler (ZS) gained 2% with strong Q4 results. Adobe (ADBE) dropped 1% on CEO transition. Planet Labs (PL) advanced 7% on Q2 earnings. Asana (ASAN) fell 10% on Q3 guidance. Guidewire (GWRE) dropped 15% on revenue outlook. Samsara (IOT) surged 14% on raised guidance. UiPath (PATH) lost 7% on Q3 outlook.

$PATHHighAI 8/10

UiPath Q2 2027: Revenue Beats, GAAP Operating Income Swings Positive

UiPath reported Q2 2027 revenue of $410.26M, up 13.4% YoY, beating estimates. GAAP operating income turned positive at $31.6M, driven by lower stock-based compensation and R&D spending. Annual recurring revenue reached $1.94B, up 12% YoY. Management guided Q3 revenue to $440-445M and announced leadership changes. The company repurchased $268.5M of its Class A common stock in the last six months.

$IOTHighAI 8/10

After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM

Samsara (IOT) rose 11% on strong Q2 results and raised guidance. UiPath (PATH) climbed 13% with solid Q2 revenue and upbeat full-year outlook. Docusign (DOCU) gained 7% after a beat-and-raise Q2 report. Asana (ASAN) fell 12% on soft near-term profitability targets. Guidewire (GWRE) dropped 19% due to weak Q1 revenue guidance. Zscaler (ZS) edged up 1% on solid fiscal Q4 results. Planet Labs (PL) jumped 5% after reporting a surprise Q2 profit. Smith & Wesson (SWBI) surged 8.6% on strong Q1 sales.

$PATHMedAI 8/10

UiPath, Inc. (PATH): Results of Operations and Financial Condition

UiPath, Inc. (PATH) filed an SEC Form 8-K — Results of Operations and Financial Condition. UiPath Reports Second Quarter Fiscal 2027 Financial Results Revenue of $410 million increased 13 percent year-over-year ARR of $1.938 billion increased 12 percent year-over-year GAAP operating income of $32 million and non-GAAP operating income of $89 million Announces leadership

$PATHMedAI 8/10

Analysts Have a Wall of Holds on Figma, UiPath and GitLab but Institutions Are Quietly Loading Up

Analysts have issued 41 Holds across 61 ratings for UiPath, GitLab, and Figma, with consensus targets below current prices for two. Institutions hold 65% to 95% of the float, building positions despite cautious analyst sentiment. UiPath and GitLab have surged 58% and 36% in one month, respectively, exceeding analyst targets. Figma's target aligns with its current price. All three companies reported strong revenue growth in recent quarters.